cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Phathom Pharmaceuticals Inc
1 own
4 watching
Current Price
$10.56
$-0.13
(-1.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
517.51M
52-Week High
52-Week High
17.01900
52-Week Low
52-Week Low
6.06500
Average Volume
Average Volume
0.52M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization517.51M
icon52-Week High17.01900
icon52-Week Low6.06500
iconAverage Volume0.52M
iconDividend Yield--
iconP/E Ratio--
What does the Phathom Pharmaceuticals Inc do?
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Read More
How much money does Phathom Pharmaceuticals Inc make?
News & Events about Phathom Pharmaceuticals Inc.
Globe Newswire
11 months ago
NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Corp. (NASDAQ: IART), Chinook Therapeutics, Inc. (NASDAQ: KDNY), Phathom Pharmaceuticals, Inc. (NASDAQ...
Globe Newswire
11 months ago
Prescription Drug User Fee Act (PDUFA) goal date of November 17, 2023Combined launch of vonoprazan for Erosive GERD and H. pylori indications planned for Q4 2023, if approved FLORHAM PARK, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical ...
PR Newswire
11 months ago
PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws PHAT FRAUD ALERT: Jakubowitz Law is Investigating Phathom Pharmaceuticals, Inc. in Connection with Potential Violations of Federal Securities Laws PR...
Ticker Report
1 year ago
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT Get Rating) COO Azmi Nabulsi acquired 10,000 shares of the businesss stock in a transaction that occurred on Tuesday, April 11th. The stock was bought at an average cost of $8.26 per share, for a total transaction of $82,600.00. Following the...
Zolmax
1 year ago
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT Get Rating) COO Azmi Nabulsi acquired 10,000 shares of the businesss stock in a transaction that occurred on Tuesday, April 11th. The stock was bought at an average cost of $8.26 per share, for a total transaction of $82,600.00. Following the completion of ...
Frequently Asked Questions
Frequently Asked Questions
What is Phathom Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Phathom Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Phathom Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Phathom Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Phathom Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Phathom Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Phathom Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Phathom Pharmaceuticals Inc?
plus_minus_icon
What percentage is Phathom Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Phathom Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$10.56
$-0.13
(-1.22%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00